Strategic Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$413K Sell
5,284
-2,404
-31% -$194K 0.09% 123
2026
Q1
$666K Sell
7,688
-611
-7% -$58.5K 0.11% 123
2025
Q4
$797K Sell
8,299
-2,445
-23% -$237K 0.12% 116
2025
Q3
$1.02M Sell
10,744
-22
-0.2% -$2.02K 0.16% 105
2025
Q2
$938K Sell
10,766
-2,050
-16% -$174K 0.18% 91
2025
Q1
$1.15M Sell
12,816
-17,340
-58% -$1.55M 0.22% 90
2024
Q4
$2.41M Sell
30,156
-3,282
-10% -$284K 0.44% 48
2024
Q3
$3.01M Buy
33,438
+215
+0.6% +$18.1K 0.56% 43
2024
Q2
$2.61M Sell
33,223
-1,521
-4% -$125K 0.51% 46
2024
Q1
$3.03M Hold
34,744
0.6% 40
2023
Q4
$2.86M Sell
34,744
-1,536
-4% -$117K 0.54% 46
2023
Q3
$2.84M Buy
36,280
+3,001
+9% +$251K 0.56% 44
2023
Q2
$2.93M Buy
33,279
+353
+1% +$30.4K 0.56% 42
2023
Q1
$2.65M Buy
32,926
+15,405
+88% +$1.26M 0.54% 43
2022
Q4
$1.36M Buy
17,521
+7,232
+70% +$586K 0.3% 74
2022
Q3
$830K Sell
10,289
-5,207
-34% -$468K 0.18% 101
2022
Q2
$1.39M Buy
15,496
+5,417
+54% +$549K 0.29% 77
2022
Q1
$1.12M Sell
10,079
-1,142
-10% -$121K 0.19% 96
2021
Q4
$1.16M Buy
11,221
+9,333
+494% +$1.08M 0.17% 107
2021
Q3
$236K Buy
+1,888
New +$244K 0.05% 169
2020
Q2
Sell
-7,519
Closed -$746K 154
2020
Q1
$746K Buy
7,519
+2,462
+49% +$262K 0.33% 69
2019
Q4
$574K Sell
5,057
-110
-2% -$12.1K 0.2% 98
2019
Q3
$561K Buy
+5,167
New +$539K 0.21% 93
2019
Q2
Sell
-5,240
Closed -$477K 162
2019
Q1
$477K Buy
5,240
+1,012
+24% +$90.6K 0.18% 100
2018
Q4
$385K Buy
4,228
+29
+0.7% +$2.71K 0.17% 102
2018
Q3
$413K Buy
+4,199
New +$388K 0.15% 112

Other funds holding MDT

Strategic Advisors's MDT Position: Q2 2026 in Review

Strategic Advisors reduced its Medtronic (MDT) stake by 31% in Q2 2026, selling an estimated $194K and leaving 5,284 shares worth $413K. The position accounts for 0.09% of the portfolio, ranked #123.

Strategic Advisors first reported a position in MDT in Q3 2018 and has held it in 26 quarters since. The position peaked at $3.03M in Q1 2024. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Strategic Advisors held 5,284 shares of Medtronic worth $413K as of Q2 2026.
  • Strategic Advisors sold 2,404 Medtronic shares in Q2 2026, an estimated $194K.
  • Medtronic made up 0.09% of Strategic Advisors's portfolio in Q2 2026, its #123 holding.
  • Strategic Advisors first reported a position in Medtronic in Q3 2018 and has held it in 26 quarters since.
  • Strategic Advisors's Medtronic position peaked at $3.03M in Q1 2024.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Strategic Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.